Link Pharma Chem Ltd Financials
Company Logo

Link Pharma Chem Ltd Financial Statement

Link Pharma Chem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue5.16
Operating Expense5.10
Net Profit-0.31
Net Profit Margin-6.01
Earning Per Share-0.69
EBIDTA0.14
Effective Tax RateTBA
Invest in Link Pharma Chem Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Link Pharma Chem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual29.90
Operating Expenses Annual30.55
Operating Profit Annual-0.01
Interest Annual0.87
Depreciation1.03
Net Profit Annual-1.36
Tax Annual-0.55

Link Pharma Chem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.09
Cash Flow from Operations-0.03
Cash Flow from Investing0.41
Cash Flow from Financing-0.41
Cash Flow at the End0.06

Link Pharma Chem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-0.03
PBIT Margin (%)-3.48
PBT Margin (%)0.53
Net PROFIT Margin (%)-4.55
Return On Networth / Equity (%)-9.46
Return On Networth /Employed (%)-4.43
Return On Assets (%)-5.78
Total Debt / Equity (X)0.63
Asset Turnover Ratio (%)1.27

Link Pharma Chem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual9.94
Total Current Assets Annual11.53
Non Current Assets Annual14.42
Total Shareholders Funds Annual13.71
Total Assets Annual25.95

Link Pharma Chem Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 24, 2024, Link Pharma Chem Ltd has a market capitalization of 18.69 Cr. Value Research classifies it as a Micro-Cap company.
No, Link Pharma Chem Ltd is not debt-free with a debt-to-equity ratio of 0.67.
In FY 2023 , Link Pharma Chem Ltd recorded a total revenue of approximately 29.90 Cr marking a significant milestone in the company's financial performance.
Link Pharma Chem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and -0.3% annually, respectively..
Link Pharma Chem Ltd's current PE ratio is -13.74.
Link Pharma Chem Ltd's ROCE averaged 5.7% from the FY ending March 2022 to 2024, with a median of 6.9%. It peaked at 14.7% in March 2022, reflecting strong capital efficiency over the period..
Link Pharma Chem Ltd's latest EBIT is Rs. -1.05 Cr, surpassing the average EBIT of Rs. 1.22 Cr over the 5 years..